The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
How to Avoid Pancreatitis When Taking Mounjaro
Pancreatitis is a rare but serious side effect that can occur with Mounjaro (tirzepatide), a prescription weight loss injection now widely used in the UK. Knowing the warning signs, understanding your individual risk factors, and following safety guidance can help you use this medication as safely as possible. This guide explains what pancreatitis is, how to recognise symptoms, and what steps to take if you're concerned. Always discuss any health worries with your GP or prescriber before, during, and after starting Mounjaro treatment.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Understanding Pancreatitis Risk with Mounjaro
Pancreatitis is inflammation of the pancreas, a gland that produces digestive enzymes and hormones like insulin. Symptoms include severe upper stomach pain (often spreading to the back), nausea, vomiting, and sometimes fever. Pancreatitis is a medical emergency and requires immediate hospital assessment.
In clinical trials of Mounjaro (tirzepatide), pancreatitis was rare. However, it has been reported in some patients taking GLP-1 and dual GIP/GLP-1 receptor agonist medications. Your risk may be higher if you have a personal or family history of pancreatitis, gallbladder problems, or certain metabolic conditions. Before starting Mounjaro, your prescriber will assess your individual risk factors during a clinical assessment. If you have previous pancreatitis or gallbladder disease, inform your healthcare provider immediately, as this may affect whether Mounjaro is suitable for you.
Dose titration — starting at a low dose (2.5 mg) and gradually increasing — may help your body adjust and minimise gastrointestinal side effects that could mask early warning signs.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Recognising Warning Signs and Taking Action
Seek urgent medical attention if you experience severe, persistent upper stomach pain (especially if it spreads to your back), alongside nausea or vomiting that doesn't improve. These are hallmark signs of acute pancreatitis. Other concerning symptoms include yellowing of skin or eyes (jaundice), fever, or rapid heartbeat. Do not wait — go to A&E or call 999 immediately if you suspect pancreatitis.
To reduce risk: take Mounjaro exactly as prescribed, follow dose increases gradually, stay well-hydrated, and report all new or unusual symptoms to your GP or prescriber promptly. If you experience persistent nausea or vomiting beyond the first few weeks, contact your healthcare provider. Avoid alcohol, which can irritate the pancreas, and maintain a balanced diet to support digestive health during treatment.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
What is the exact risk of pancreatitis with Mounjaro in the UK?
Pancreatitis is rare with Mounjaro. In SURMOUNT clinical trials, the incidence was low. However, all GLP-1 and dual GIP/GLP-1 medications carry a theoretical pancreatitis risk. Your personal risk depends on your medical history, other medications, and individual factors. Your prescriber will assess this during your clinical assessment before starting treatment.
Can I reduce my pancreatitis risk by changing my Mounjaro dose?
Starting at the lowest dose (2.5 mg) and increasing gradually may help your body adjust and allow you to recognise side effects early. Never adjust your dose without discussing with your prescriber. Dose titration is a standard, evidence-based approach designed to improve safety and tolerability. Your GP or prescriber will guide your personalised dose schedule.
Does my GP need to monitor me for pancreatitis while taking Mounjaro?
Yes, ongoing communication with your prescriber is important. Report any new symptoms, especially stomach pain, immediately. Your GP may arrange baseline liver and pancreatic enzyme tests before starting Mounjaro. Regular check-ins allow your healthcare team to monitor for any concerning changes and adjust treatment if needed.
What should I do if I have a history of gallbladder problems before starting Mounjaro?
Inform your prescriber about any gallbladder disease, gallstones, or previous pancreatitis before starting treatment. These conditions increase pancreatitis risk. Your prescriber may decide Mounjaro is not suitable, or may recommend closer monitoring. Never start Mounjaro without disclosing your full medical history during clinical assessment.
Are there warning signs of pancreatitis I might miss because of normal Mounjaro side effects?
Mounjaro commonly causes mild-to-moderate nausea, stomach pain, and vomiting, especially in the first weeks. However, these usually improve as your body adjusts. Pancreatitis pain is typically more severe, persistent, and spreading to the back. If pain worsens or doesn't improve within a few days, or if you develop high fever or yellowing of skin, seek urgent medical attention rather than assuming it's a normal Mounjaro side effect.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.